[go: up one dir, main page]

CN119280194B - Sildenafil oral film-dissolving agent, and preparation method and application thereof - Google Patents

Sildenafil oral film-dissolving agent, and preparation method and application thereof

Info

Publication number
CN119280194B
CN119280194B CN202411244983.3A CN202411244983A CN119280194B CN 119280194 B CN119280194 B CN 119280194B CN 202411244983 A CN202411244983 A CN 202411244983A CN 119280194 B CN119280194 B CN 119280194B
Authority
CN
China
Prior art keywords
sildenafil
film
coating
orally disintegrating
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202411244983.3A
Other languages
Chinese (zh)
Other versions
CN119280194A (en
Inventor
赵玉姣
林美
练华杰
李宪楠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenex Corp
Original Assignee
Regenex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenex Corp filed Critical Regenex Corp
Priority to CN202411244983.3A priority Critical patent/CN119280194B/en
Publication of CN119280194A publication Critical patent/CN119280194A/en
Application granted granted Critical
Publication of CN119280194B publication Critical patent/CN119280194B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种西地那非口溶膜剂及其制备方法与应用,所述西地那非口溶膜剂包括如下物料:枸橼酸西地那非和/或其药学上可接受的盐、甲基丙烯酸甲胺基酯类共聚物、高分子成膜材料、抗粘剂、维生素C、增塑剂和保湿剂。本发明的口溶膜剂不仅可以有效掩盖西地那非本身苦异味,还具有良好口感和较短的崩解时间,解决了传统枸橼酸西地那非口溶膜在服用过程口感较苦的问题。另外,该口溶膜剂还具有良好的物理性能和药物稳定性,能够满足药物的保存、运输以及临床使用等需求。The present invention discloses a sildenafil orally disintegrating film, a preparation method, and an application thereof. The sildenafil orally disintegrating film comprises the following materials: sildenafil citrate and/or a pharmaceutically acceptable salt thereof, a methylamino methacrylate copolymer, a polymer film-forming material, an anti-adherent agent, vitamin C, a plasticizer, and a moisturizer. The orally disintegrating film of the present invention can not only effectively mask the bitter taste of sildenafil itself, but also has a good mouthfeel and a short disintegration time, thereby solving the problem of a bitter taste during the administration of traditional sildenafil citrate orally disintegrating films. In addition, the orally disintegrating film also has good physical properties and drug stability, and can meet the requirements of drug storage, transportation, and clinical use.

Description

Sildenafil oral film-dissolving agent, and preparation method and application thereof
Technical Field
The invention relates to the technical field of pharmaceutical preparation materials, in particular to a sildenafil oral film agent, a preparation method and application thereof.
Background
Erectile dysfunction (Erectiledysfunction, ED) is a common disease of sexual dysfunction and is clinically characterized by a failure of the penis to maintain adequate erection for more than 3 months in sexual activity. Drugs that have been marketed for the treatment of erectile dysfunction include PDE-5 inhibitors such as sildenafil, vardenafil, tadalafil, and atorvastatin. Among them, sildenafil citrate is the drug of choice for the clinical treatment of various types of erectile dysfunction at present, and the dosage form on the market is a tablet. The traditional tablet has the problems of water requirement for oral administration, low compliance and the like, and the newly developed oral solid quick-release preparation can realize convenient administration and quick dissolution in the oral cavity.
The oral solid quick-release preparation comprises orally disintegrating tablet, sublingual tablet, dispersible tablet and oral instant film. The oral instant film is a preparation prepared by dispersing effective components of a certain dose of chemicals or traditional Chinese medicine extracts in film forming materials, can be rapidly dissolved in the oral cavity, and has the advantages of difficult spitting, rapid absorption, rapid onset of action, convenient swallowing and the like. The sildenafil citrate oral solution film is rapidly disintegrated in the oral cavity in the taking process, and related components of the sildenafil citrate oral solution film can be fully contacted with the oral cavity, so that the taste of the sildenafil citrate oral solution film is particularly bitter, and the existing process usually uses a sweetener or a taste masking agent to improve the taste, but the problem that the sildenafil oral solution film has bitter taste in the taking process is still difficult to solve.
Disclosure of Invention
In order to overcome the problems of the prior art, one of the purposes of the present invention is to provide a sildenafil oral film. The second purpose of the invention is to provide a preparation method of the sildenafil oral film.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
The invention provides sildenafil oral solution, which comprises sildenafil citrate and/or pharmaceutically acceptable salts thereof, methacrylic acid methylamino ester copolymer, high polymer film forming material, anti-adhesive, vitamin C, plasticizer, humectant and cooling agent, wherein the mass ratio of the methacrylic acid methylamino ester copolymer to the anti-adhesive to the vitamin C is 1 (0.03-0.3) (0.15-0.7).
Preferably, the mass ratio of the methacrylic acid methylamino ester copolymer to the anti-adhesion agent to the vitamin C is 1 (0.05-0.15) (0.2-0.55).
More preferably, the mass ratio of the methyl methacrylate amino ester copolymer, sildenafil citrate and/or pharmaceutically acceptable salt thereof to the polymer film forming material is 1 (0.85-1.8) (3-7.5).
Preferably, the composition comprises 14-18 parts by mass of sildenafil citrate and/or pharmaceutically acceptable salt thereof, 10-16 parts by mass of methylamino methacrylate copolymer, 40-75 parts by mass of polymer film forming material, 0.5-3 parts by mass of anti-sticking agent, 3-7 parts by mass of vitamin C, 2-15 parts by mass of plasticizer and 2-5 parts by mass of humectant.
More preferably, the mass part of the polymer film forming material is 50-65 parts.
More preferably, the plasticizer is 3 to 10 parts by mass.
Preferably, the polymer film forming material is at least one selected from polyvinyl alcohol, hydroxypropyl cellulose, hypromellose and copovidone.
More preferably, the polymeric film-forming material is selected from polyvinyl alcohol and hypromellose.
Further preferably, the mass ratio of the polyvinyl alcohol to the hypromellose is 1 (1-2).
Preferably, the anti-sticking agent is at least one selected from talcum powder, magnesium stearate and stearic acid.
Preferably, the plasticizer is at least one selected from polyethylene glycol, propylene glycol, and triethyl citrate.
Preferably, the humectant is glycerin.
Preferably, the cooling agent is at least one selected from menthol, N,2, 3-trimethyl-2-isopropyl butyramide and menthol.
Preferably, the methylamino methacrylate copolymer is a butyl methacrylate-dimethylaminoethyl methacrylate-methyl methacrylate copolymer.
More preferably, the ratio of the number of structural units of butyl methacrylate, dimethylaminoethyl methacrylate and methyl methacrylate in the butyl methacrylate-dimethylaminoethyl methacrylate-methyl methacrylate copolymer is 1:2:1.
Further preferably, the methylamino methacrylate copolymer is Eudragit E100 or Eudragit EPO.
Preferably, the particle size D90 of sildenafil citrate and/or pharmaceutically acceptable salt thereof is not more than 10 μm.
The second aspect of the invention provides a preparation method of the sildenafil oral film agent in the first aspect, which comprises the following steps:
S1, carrying out fluidization coating on sildenafil citrate and/or pharmaceutically acceptable salts thereof by adopting an organic solution containing a methacrylic acid methylamino ester copolymer and an anti-sticking agent to prepare sildenafil taste masking particles;
s2, mixing sildenafil taste masking particles, a high polymer film forming material, vitamin C, a plasticizer, a humectant and a cooling agent in water to obtain slurry, coating and forming a film, and drying and cutting to obtain the sildenafil oral solution film agent.
Preferably, the solvent of the organic solution is an aqueous ethanol solution.
More preferably, the organic solution is prepared by dissolving the methylamino methacrylate copolymer in ethanol water solution, adding the anti-adhesion agent, and mixing to obtain the organic solution containing the methylamino methacrylate copolymer and the anti-adhesion agent.
Preferably, in step S1, the fluidized coating is performed by using a fluidized bed bottom spray coater.
Preferably, in step S1, the material temperature is 22-25 ℃ during the fluidized coating process.
Preferably, in the step S1, the mass ratio of the sildenafil citrate to the sildenafil taste-masking particles is 1 (1.7-2.1).
Preferably, at least one of a sweetener and a flavoring agent is further added in step S2.
More preferably, the sweetener is at least one selected from steviosin, mogroside, sucralose, sugar alcohol, acesulfame potassium, and aspartame.
More preferably, the aromatic is at least one selected from strawberry flavor essence, juicy peach flavor essence, pomegranate flavor essence, and orange flavor essence.
Preferably, step S2 further comprises defoaming.
More preferably, the defoaming mode is standing defoaming.
Preferably, in the step S2, in the process of coating and film forming, the thickness of the paving film is 0.15-0.2mm, and the coating speed is 20-40cm/min.
Preferably, in step S2, the drying temperature is 50-70 ℃.
The beneficial effects of the invention are as follows:
the invention provides a sildenafil oral film, which adopts a coating formed by methacrylic acid methylamino ester copolymer and an anti-adhesive to reduce the bitter taste of sildenafil, the cooling agent further reduces the bitter taste, and the vitamin C has the effect of an acidulant, so that the specific proportion of the methacrylic acid methylamino ester copolymer, the anti-adhesive and the vitamin C is adopted, on one hand, the feeling of the oral cavity on the bitter taste is reduced, and on the other hand, the secretion of saliva is promoted, and the dissolution time of a film agent polymer film forming material in the oral cavity is shortened, so that taste masking particles are accelerated to enter the gastrointestinal tract, and the contact time of the taste masking particles and the oral cavity is reduced, thereby realizing that bitter feeling is not released in the oral cavity. The oral film can not only effectively mask the bitter peculiar smell of sildenafil, but also has good taste and shorter disintegration time, and solves the problem that the traditional sildenafil citrate oral film has bitter taste in the taking process. In addition, the oral film has good physical properties and drug stability, and can meet the requirements of storage, transportation, clinical use and the like of the drug.
The invention also provides a preparation method of the sildenafil oral solution, the addition of the anti-sticking agent in the coating process is favorable for the smooth operation of spray coating, and the prepared sildenafil oral solution has no gritty feel and no bitter taste in the taking process, has good taste, improves the clinical use compliance of the existing dosage forms on the market, and has clinical development and use values.
Detailed Description
The present invention will be described in further detail with reference to specific examples. The materials used in the examples below, unless otherwise specified, were either commercially available or isolated by simple synthetic preparation, and the procedures employed, unless otherwise specified, were all conventional in the art.
Example 1
The embodiment provides a sildenafil oral film, the specific formula of which is shown in table 1, and the sildenafil oral film is prepared from the following components:
TABLE 1
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 98% to obtain sildenafil taste masking granule;
2. 160 parts by mass of purified water (about 1565g of raw materials corresponds to 2500g of water) are weighed, heated to 50 ℃, polyvinyl alcohol, polyethylene glycol 400 and glycerin are added into the purified water, stirred and homogenized, cooled to room temperature, the prepared sildenafil taste-masking particles, vitamin C, hypromellose, steviosin, N,2, 3-trimethyl-2-isopropyl butyramide are added, mixed and stirred to prepare a solution, standing overnight to remove bubbles, a backing material is arranged, a coating dryer is arranged at a drying temperature of 60 ℃, coating and drying are started, the coating speed is 0.3 m/min, the film thickness is 0.17mm, the sildenafil oral solution film with the tablet weight of about 313mg is obtained after cutting according to proper size, and the sildenafil oral solution film is independently packaged by adopting a composite film bag.
Example 2
The embodiment provides a sildenafil oral film, the specific formula of which is shown in table 2, and the sildenafil oral film is prepared from the following components:
TABLE 2
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 100% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and N,2, 3-trimethyl-2-isopropyl butyramide, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to be 70 ℃, starting coating and drying, the coating speed is 0.3 m/min and the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Example 3
The embodiment provides a sildenafil oral film, the specific formula of which is shown in table 3, and the sildenafil oral film is prepared from the following components:
TABLE 3 Table 3
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and N,2, 3-trimethyl-2-isopropyl butyramide which are prepared by the steps of mixing and stirring, preparing a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to 55 ℃, starting coating and drying, the coating speed is 0.3 m/min and the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Example 4
The embodiment provides a sildenafil oral film, the specific formula of which is shown in table 4, and the sildenafil oral film is prepared from the following components:
TABLE 4 Table 4
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding 20% polyethylene glycol 400 of talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not more than 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature in the coating process is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste-masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, residual polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and N,2, 3-trimethyl-2-isopropyl butyramide, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to 55 ℃, starting coating and drying, the coating speed is 0.3 m/min and the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Comparative example 1
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 5, and the film is prepared from the following components:
TABLE 5
The preparation method of the sildenafil oral film agent comprises the following steps:
Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding sildenafil citrate raw material powder, vitamin C, hypromellose, steviosin, N,2, 3-trimethyl-2-isopropyl butyramide, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting a coating dryer at a drying temperature of 55 ℃, starting coating and drying, coating at a coating speed of 0.3 m/min and a film thickness of 0.17mm, cutting according to a proper size to obtain sildenafil oral solution film with a piece weight of about 313mg, and independently packaging the sildenafil oral solution film by adopting a composite film bag.
Comparative example 2
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 6, and the film is prepared from the following components:
TABLE 6
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, hypromellose, steviosin, N,2, 3-trimethyl-2-isopropyl butyramide, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting a coating dryer at a drying temperature of 55 ℃, starting coating and drying, enabling the coating speed to be 0.3 m/min, enabling the film thickness to be 0.17mm, cutting according to a proper size to obtain sildenafil oral solution film with the weight of 313mg, and independently packaging the sildenafil oral solution film by adopting a composite film bag.
Comparative example 3
The comparative example provides a sildenafil oral film, the specific formula of which is shown in Table 7, and the film is prepared from the following components:
TABLE 7
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40min to dissolve, preparing solution with concentration of 20wt%, adding silicon dioxide, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coater, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and N,2, 3-trimethyl-2-isopropyl butyramide which are prepared by the steps of mixing and stirring, preparing a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to 55 ℃, starting coating and drying, the coating speed is 0.3 m/min and the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Comparative example 4
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 8, and the film is prepared from the following components:
TABLE 8
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit L100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and N,2, 3-trimethyl-2-isopropyl butyramide which are prepared by the steps of mixing and stirring, preparing a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to 55 ℃, starting coating and drying, the coating speed is 0.3 m/min and the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Comparative example 5
The comparative example provides a sildenafil oral film, the specific formula of which is shown in Table 9, and the film is prepared from the following components:
TABLE 9
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Dissolving Eudragit E100 in 95% ethanol as binder, adding sildenafil citrate and talcum powder into wet granulator, mixing, adding binder, granulating for 10 min, and granulating at blade speed of 1500rpm and cutting knife rotation speed of 150rpm to obtain sildenafil taste-masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and essence, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting a coating dryer at a drying temperature of 55 ℃, starting coating and drying, wherein the coating speed is 0.3 m/min, the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution film with the weight of 313mg, and independently packaging the sildenafil oral solution film by adopting a composite film bag.
Comparative example 6
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 10, and the film is prepared from the following components:
table 10
Material name Action Parts by mass
Sildenafil citrate Bulk drug 16
Eud E100 Taste masking material 13
Talc powder Anti-sticking agent 2.6
Polyvinyl alcohol Film-forming material 38.4
Hydroxypropyl methylcellulose Film-forming material 17
Vitamin C Sour agent 5
Polyethylene glycol Plasticizer(s) 6
Glycerol Humectant type 4
Steviosin (stevia rebaudiana) Sweetener composition 0.2
Sweet orange flavor essence Aromatic agent 0.5
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 25-30deg.C, and the coating weight is increased by 98% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, hypromellose, steviosin and sweet orange essence, mixing and stirring to prepare a solution, standing overnight to remove bubbles, setting a backing material, setting a coating dryer at 60 ℃, starting coating and drying, wherein the coating speed is 0.3 m/min, the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Comparative example 7
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 11, and the film is prepared from the following components:
TABLE 11
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 of 25 μm by using fluidized bed bottom spray coater, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 98% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, vitamin C, hypromellose, steviosin and orange flavor prepared by the method, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting a coating dryer at 60 ℃, starting coating and drying, enabling the coating speed to be 0.3 m/min and the film thickness to be 0.17mm, cutting according to a proper size to obtain sildenafil oral solution film with the weight of about 313mg, and independently packaging the sildenafil oral solution film by adopting a composite film bag.
Comparative example 8
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 12, and the film is prepared from the following components:
table 12
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 50% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the sildenafil taste-masking particles, hypromellose, steviosin, N,2, 3-trimethyl-2-isopropyl butyramide, mixing and stirring to prepare a solution, standing overnight to remove bubbles, installing a backing material, setting the drying temperature of a coating dryer to 60 ℃, starting coating and drying, enabling the coating speed to be 0.3 m/min, enabling the film thickness to be 0.17mm, cutting according to a proper size to obtain sildenafil oral solution film with the weight of 313mg, and independently packaging the sildenafil oral solution film by adopting a composite film bag.
Comparative example 9
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 13, and the film is prepared from the following components:
TABLE 13
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 22-25deg.C, and the coating weight is increased by 80% to obtain sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, hypromellose, steviosin and sweet orange essence, mixing and stirring to prepare a solution, standing overnight to remove bubbles, setting a backing material, setting a coating dryer at a drying temperature of 55 ℃, starting coating and drying, wherein the coating speed is 0.3 m/min, the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Comparative example 10
The comparative example provides a sildenafil oral film, the specific formula of which is shown in table 14, and the film is prepared from the following components:
TABLE 14
The preparation method of the sildenafil oral film agent comprises the following steps:
1. Adding Eudragit E100 into 95% ethanol, stirring for 40 min to dissolve, preparing solution with concentration of 20wt%, adding talcum powder, stirring and dispersing uniformly to obtain coating solution, and performing bottom spray coating on sildenafil citrate powder with particle diameter D90 not exceeding 10 μm by using fluidized bed bottom spray coating machine, wherein the material temperature is 32-36 ℃ during coating process, and the coating weight is increased by 80%, thus obtaining sildenafil taste masking granule;
2. Weighing 160 parts by mass of purified water, heating to 50 ℃, adding polyvinyl alcohol, polyethylene glycol 400 and glycerin into the purified water, stirring and homogenizing, cooling to room temperature, adding the prepared sildenafil taste-masking particles, hypromellose, steviosin and sweet orange essence, mixing and stirring to prepare a solution, standing overnight to remove bubbles, setting a backing material, setting a coating dryer at a drying temperature of 35 ℃, starting coating and drying, wherein the coating speed is 0.3 m/min, the film thickness is 0.17mm, cutting according to a proper size to obtain sildenafil oral solution films with the weight of about 313mg, and independently packaging the sildenafil oral solution films by adopting a composite film bag.
Performance test and results
1. The samples obtained in examples 1 to 4 and comparative examples 1 to 10 were subjected to a taste test.
10 Male and female volunteers 20-45 years old were selected, samples of examples 1-4 and comparative examples 1-10 were tried after 20min interval and drinking water rinse, respectively, and the scoring results were averaged, and the bitter scores were as shown in table 15 below. The scoring standard is that the whole course is almost free of bitter, the bitter is a little after 2-entrance for 5 seconds, the bitter is obvious in 3-entrance for 5 seconds, each group is the average value of scores of all volunteers, and the whole number is rounded off by adopting a rounding principle.
TABLE 15
2. The samples obtained in examples 1 to 4 and comparative examples 1 to 10 were subjected to oral film appearance, tensile strength, folding endurance and disintegration time test.
(1) Test method
Appearance detection, visual inspection under white light.
The tensile strength detection method comprises the steps of adopting a texture analyzer, setting the speed to be 100mm/min, clamping a sample on an instrument clamp after the measurement condition is set, and starting measurement after the initial value is reset to zero.
The method for measuring the folding endurance comprises the steps of taking 1 piece of the product, folding the piece of the product, placing the piece of the product on a PVC plate, adding about 500g of weight for 2s on the PVC plate, repeating the operation, and recording the folding times when the sample breaks.
Determination of disintegration time 25ml of purified water was added to a 250ml beaker and the water bath temperature was 37.+ -. 0.5 ℃. The paper clip is fixed at the middle position of the oral film, the paper clip is placed into a beaker to start timing until the oral film is completely dissolved, the time required by the complete dissolution of the oral film is recorded, and the measurement is repeated for 3 times.
(2) The test results are shown in table 16:
table 16
As can be seen from tables 15 and 16, examples 1 to 4 tested the feasibility of the product process, the appearance, the disintegration time and the taste of the product under different process parameters such as different weight gains of the taste masking coating, different coating drying temperatures, and the like, and did not greatly affect the quality of the product.
As can be seen from tables 15 and 16, the conventional taste masking method using sweetener and cooling agent adopted in comparative example 1 was free of addition of particular E100 coating, the bitter taste of the oral film after 5 seconds in the coating process was obvious, the E100 of comparative example 2 was free of addition of vitamin C and bitter taste after 5 seconds in the coating process, the anti-sticking agent type, the taste masking agent type and the granulating method were replaced in comparative examples 3,4 and 5 respectively, the oral film still had little bitter taste after 5 seconds in the coating process, the coating process was not smooth and the taste masking effect was reduced due to adhesion of the taste masking particles caused by softening of the coating material when the coating temperature was too high in comparative example 6, the effect of the particle size of the raw material was examined in comparative example 7, the appearance of the film was not qualified when the particle size of the raw material was 25 μm was used, the dosage ratio of different talcum powder in the coating was examined in comparative examples 8 and 9, a little bitter taste was still remained after 5 seconds in the inlet, and the surface of the film was not sufficiently smooth due to insufficient drying when the coating drying temperature was too low in comparative example 10.
In conclusion, the invention adopts the Eudragit E100 and talcum powder to carry out fluidized bed bottom spray coating on sildenafil, uses N,2, 3-trimethyl-2-isopropyl butyramide as a cooling agent and vitamin C to regulate bitter taste, and limits specific coating and coating conditions.
3. The samples of example 1, comparative example 4, comparative examples 8-10 were individually packaged using a composite film pouch and stability was investigated under accelerated (40 ℃ at 75% rh) conditions, the results of which are shown in table 17:
TABLE 17
As can be obtained from table 17, the sildenafil oral solution film prepared by the technology adopted by the invention has good quality stability and meets the requirements when the sample of the example 1 is placed for 6 months under the acceleration condition, and the folding endurance, the content and the disintegration time limit of the sildenafil oral solution film are not obviously changed. The comparative example 4 and comparative examples 8-10 show a decrease in sildenafil citrate content and a decrease in folding endurance of the film agent during stability than the examples.
The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the protection scope of the present invention.

Claims (8)

1.一种西地那非口溶膜剂,其特征在于,包括如下物料:枸橼酸西地那非和/或其药学上可接受的盐、甲基丙烯酸甲胺基酯类共聚物、高分子成膜材料、抗粘剂、维生素C、增塑剂、保湿剂和凉味剂;所述甲基丙烯酸甲胺基酯类共聚物、抗粘剂与维生素C的质量比为1:(0.03-0.3):(0.15-0.7);所述甲基丙烯酸甲胺基酯类共聚物、枸橼酸西地那非和/或其药学上可接受的盐与高分子成膜材料的质量比为1:(0.85-1.8):(3-7.5);所述甲基丙烯酸甲胺基酯类共聚物为尤特奇E100;1. A sildenafil orally disintegrating film-forming agent, characterized in that it comprises the following materials: sildenafil citrate and/or a pharmaceutically acceptable salt thereof, a methylamino methacrylate copolymer, a polymer film-forming material, an anti-adherent agent, vitamin C, a plasticizer, a humectant, and a cooling agent; the mass ratio of the methylamino methacrylate copolymer, the anti-adherent agent, and the vitamin C is 1:(0.03-0.3):(0.15-0.7); the mass ratio of the methylamino methacrylate copolymer, sildenafil citrate and/or a pharmaceutically acceptable salt thereof, and the polymer film-forming material is 1:(0.85-1.8):(3-7.5); the methylamino methacrylate copolymer is Eudragit E100; 所述抗粘剂为滑石粉;所述凉味剂为N,2,3-三甲基-2-异丙基丁酰胺;The anti-sticking agent is talc; the cooling agent is N,2,3-trimethyl-2-isopropylbutanamide; 所述西地那非口溶膜剂是包括如下步骤的制备方法制得:The sildenafil orally disintegrating film is prepared by a preparation method comprising the following steps: S1、采用含有甲基丙烯酸甲胺基酯类共聚物和抗粘剂的有机溶液对枸橼酸西地那非和/或其药学上可接受的盐进行流化包衣,制得西地那非掩味颗粒;所述流化包衣过程中的物料温度为22-25℃;S1. Fluidizing and coating sildenafil citrate and/or a pharmaceutically acceptable salt thereof with an organic solution containing a methylamino methacrylate copolymer and an anti-adherent agent to prepare sildenafil taste-masked particles; the material temperature during the fluidizing and coating process is 22-25° C.; S2、将西地那非掩味颗粒、高分子成膜材料、维生素C、增塑剂、保湿剂和凉味剂在水中进行混合得到浆料,进行涂布制膜,再经干燥和分切,制得西地那非口溶膜剂。S2. Mix the sildenafil taste-masking particles, polymer film-forming material, vitamin C, plasticizer, moisturizer and cooling agent in water to obtain a slurry, apply the slurry to form a film, and then dry and cut the slurry to obtain the sildenafil orally disintegrating film. 2.根据权利要求1所述的西地那非口溶膜剂,其特征在于,所述甲基丙烯酸甲胺基酯类共聚物、抗粘剂与维生素C的质量比为1:(0.05-0.15):(0.2-0.55)。2. The sildenafil orally disintegrating film according to claim 1, characterized in that the mass ratio of the methylamino methacrylate copolymer, the anti-adherent agent and vitamin C is 1:(0.05-0.15):(0.2-0.55). 3.根据权利要求1所述的西地那非口溶膜剂,其特征在于,包括如下质量份的物料:枸橼酸西地那非和/或其药学上可接受的盐14-18份、甲基丙烯酸甲胺基酯类共聚物10-16份、高分子成膜材料40-75份、抗粘剂0.5-3份、维生素C3-7份、增塑剂2-15份、保湿剂2-5份和凉味剂0.2-1份。3. The sildenafil orally disintegrating film according to claim 1, characterized in that it comprises the following materials in parts by weight: 14-18 parts of sildenafil citrate and/or a pharmaceutically acceptable salt thereof, 10-16 parts of methylamino methacrylate copolymer, 40-75 parts of a polymer film-forming material, 0.5-3 parts of an anti-adherent agent, 3-7 parts of vitamin C, 2-15 parts of a plasticizer, 2-5 parts of a humectant, and 0.2-1 parts of a cooling agent. 4.根据权利要求1所述的西地那非口溶膜剂,其特征在于,所述高分子成膜材料选自聚乙烯醇、羟丙基纤维素、羟丙甲纤维素、共聚维酮中的至少一种。4. The sildenafil orally disintegrating film-forming preparation according to claim 1, wherein the polymer film-forming material is selected from at least one of polyvinyl alcohol, hydroxypropyl cellulose, hypromellose, and copovidone. 5.根据权利要求1所述的西地那非口溶膜剂,其特征在于,所述增塑剂选自聚乙二醇、丙二醇、柠檬酸三乙酯中的至少一种;5. The sildenafil orally disintegrating film according to claim 1, wherein the plasticizer is at least one selected from the group consisting of polyethylene glycol, propylene glycol, and triethyl citrate; 和/或,所述保湿剂为甘油。And/or, the humectant is glycerin. 6.权利要求1-5任一项所述西地那非口溶膜剂的制备方法,其特征在于,包括如下步骤:6. The method for preparing the sildenafil orally disintegrating film according to any one of claims 1 to 5, comprising the steps of: S1、采用含有甲基丙烯酸甲胺基酯类共聚物和抗粘剂的有机溶液对枸橼酸西地那非和/或其药学上可接受的盐进行流化包衣,制得西地那非掩味颗粒;所述流化包衣过程中的物料温度为22-25℃;S1. Fluidizing and coating sildenafil citrate and/or a pharmaceutically acceptable salt thereof with an organic solution containing a methylamino methacrylate copolymer and an anti-adherent agent to prepare sildenafil taste-masked particles; the material temperature during the fluidizing and coating process is 22-25° C.; S2、将西地那非掩味颗粒、高分子成膜材料、维生素C、增塑剂、保湿剂和凉味剂在水中进行混合得到浆料,进行涂布制膜,再经干燥和分切,制得西地那非口溶膜剂。S2. Mix the sildenafil taste-masking particles, polymer film-forming material, vitamin C, plasticizer, moisturizer and cooling agent in water to obtain a slurry, apply the slurry to form a film, and then dry and cut the slurry to obtain the sildenafil orally disintegrating film. 7.根据权利要求6所述西地那非口溶膜剂的制备方法,其特征在于,步骤S2的浆料还加入甜味剂和芳香剂中的至少一种。7. The method for preparing the orally disintegrating sildenafil film-forming agent according to claim 6, wherein at least one of a sweetener and a flavoring agent is further added to the slurry in step S2. 8.根据权利要求6所述西地那非口溶膜剂的制备方法,其特征在于,所述涂布制膜的过程中,铺膜厚度为0.15-0.2mm,涂膜速度为20-40cm/min。8. The method for preparing the orally disintegrating sildenafil film according to claim 6, wherein during the coating process, the film thickness is 0.15-0.2 mm and the coating speed is 20-40 cm/min.
CN202411244983.3A 2024-09-06 2024-09-06 Sildenafil oral film-dissolving agent, and preparation method and application thereof Active CN119280194B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202411244983.3A CN119280194B (en) 2024-09-06 2024-09-06 Sildenafil oral film-dissolving agent, and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202411244983.3A CN119280194B (en) 2024-09-06 2024-09-06 Sildenafil oral film-dissolving agent, and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN119280194A CN119280194A (en) 2025-01-10
CN119280194B true CN119280194B (en) 2025-10-28

Family

ID=94167946

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202411244983.3A Active CN119280194B (en) 2024-09-06 2024-09-06 Sildenafil oral film-dissolving agent, and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN119280194B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113197867A (en) * 2021-05-07 2021-08-03 济川(上海)医学科技有限公司 Fexofenadine taste-masking granules, taste-masking composition and taste-masking preparation containing fexofenadine taste-masking granules, and preparation method and application of fexofenadine taste-masking granules
US11179331B1 (en) * 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002362772B2 (en) * 2001-10-12 2007-09-06 Aquestive Therapeutics, Inc. Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8603514B2 (en) * 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
CA2864322C (en) * 2012-02-28 2016-08-09 Seoul Pharma. Co., Ltd. High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179331B1 (en) * 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
CN113197867A (en) * 2021-05-07 2021-08-03 济川(上海)医学科技有限公司 Fexofenadine taste-masking granules, taste-masking composition and taste-masking preparation containing fexofenadine taste-masking granules, and preparation method and application of fexofenadine taste-masking granules

Also Published As

Publication number Publication date
CN119280194A (en) 2025-01-10

Similar Documents

Publication Publication Date Title
US10092651B2 (en) High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
EP2717852B1 (en) Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
CN103974695A (en) Bitter taste masked oral thin film formulation of sildenafil citrate
US20090311321A1 (en) Oral disintegrating tablet having masked bitter taste and method for production thereof
JP5973467B2 (en) Sildenafil free base-containing film preparation and method for producing the same
CN114886874A (en) Oral instant film agent and preparation method thereof
JP3415835B2 (en) Oral fast disintegrating tablet and method for producing the same
US10226450B2 (en) Pharmaceutical film composition
CN111939140A (en) Aripiprazole oral instant film agent and preparation method thereof
CN104546807A (en) Olanzapine oral fast dissolving film preparation
CN117224509B (en) Rupatadine orally dissolving film composition, preparation method and application thereof
CN119280194B (en) Sildenafil oral film-dissolving agent, and preparation method and application thereof
CN115869290A (en) Cetirizine oral film and preparation method thereof
CN1883456A (en) Flavor-hidden pharmaceutical granule, preparation method and use thereof
CN118948808A (en) A kind of milobarlin besylate orodispersible film preparation and preparation method thereof
WO2025026438A1 (en) Pramipexole oral soluble film composition, preparation method therefor and use thereof
CN117618399A (en) Suvorexant oral dissolved film with high bioavailability and preparation method and application thereof
CN113440499B (en) Folic acid oral dissolving film agent and preparation method thereof
CN115025067B (en) Orally dissolving film, tadalafil orally dissolving film and preparation method thereof
CN101849926B (en) Zolpidem tartrate film
JP2021506986A (en) Film formulations containing vardenafil, their preparations, and their use
CN118615260A (en) A pharmaceutical composition of perampanel orodispersible film and a preparation method thereof
CN116270553A (en) A kind of edenafil orally dissolving film and preparation method thereof
CN106176691A (en) A kind of molten membrane of escitalopram oxalate mouth and preparation method thereof
JP7681779B1 (en) solid composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant